← Retour au Screener

Sector: Santé
Open in Terminal → AMNLive chart · Key metrics · News · Smart money

AMN Healthcare Services Inc

AMN Small Cap

Healthcare · Medical Care Facilities

Mis à jour: Jun 18, 2026, 22:21 UTC

27,01 €
-4.32% aujourd'hui
52W: 12,96 € – 28,88 €
52W Low: 12,96 € Position: 88.2% 52W High: 28,88 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
28.53x
P/E prévisionnel
P/S Ratio
0.35x
Cours/Ventes
EV/EBITDA
5x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
1,0 Md €
Capitalisation boursière
Croissance du CA
99.9%
Croissance du CA sur un an
Marge bénéficiaire
-0.95%
Marge nette
ROE
-4.54%
Rentabilité des capitaux propres
Beta
0.44
Sensibilité au marché
Positions vendeuses
8.39%
% du flottant vendu à découvert
Volume moyen
1,026,969
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Conserver
7 analysts
Avg. Price Target
24,53 €
-9.16% upside
Target Range
19,18 € – 31,38 €

About the Company

Sector: Healthcare Industry: Medical Care Facilities Country: United States Employees: 2,664 Exchange: NYQ

AMN Healthcare Services Inc en bref

AMN Healthcare Services Inc (AMN) is currently trading at 27,01 € with a market capitalization of 1,0 Md €. The 52-week range spans from 12,96 € to 28,88 €; the current price is 6.5% below the yearly high. Year-over-year revenue growth stands at +99.9%.

💰 Dividende

AMN Healthcare Services Inc currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

7 analystes évaluent AMN Healthcare Services Inc (AMN) au consensus : Conserver. L'objectif de cours moyen est de 24,53 €, soit un potentiel de -9.16% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 19,18 € à 31,38 €.

AMN Healthcare Services Inc : la thèse d'investissement en détail

AMN Healthcare Services Inc (AMN) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 99.9% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Valorisation en contexte

The PEG ratio at 1.22 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 5x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

Thèse d'investissement : forces et faiblesses

Points forts
  • Forte croissance du CA de 99.9% sur un an
  • Free cash flow positif
Points faibles
  • Actuellement non rentable

Aperçu technique

MM 50 jours
22,16 €
+21.87% vs. cours
MM 200 jours
17,66 €
+52.91% vs. cours
Sous le plus haut 52s
−6.5%
28,88 €
Au-dessus du plus bas 52s
+108.3%
12,96 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.44 · Défensive
Évolue moins que le marché global
Positions vendeuses
8.39% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
108.99 · Élevé
Dette totale / capitaux propres

The data points to relatively defensive market behavior, elevated short interest (8.39%), higher leverage relative to equity.

Trading Data

50-Day MA: 22,16 €
200-Day MA: 17,66 €
Volume: 721,736
Avg. Volume: 1,026,969
Short Ratio: 2.02
P/B Ratio: 1.68x
Debt/Equity: 108.99x
Free Cash Flow: 585 M €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy AMN Healthcare Services Inc?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut